别名:Cyclin-L; CCNL1;应用:WB,IHC
反应种属:Human,Mouse,Rat
规格:50μl/100μl
Description |
---|
Transcriptional regulator which participates in regulating the pre-mRNA splicing process. Seems to be involved in the regulation of RNA polymerase II (pol II). Functions in association with cyclin-dependent kinases (CDKs) and has a role in the second step of splicing. May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC). Inhibited by the CDK-specific inhibitor p21.A. Hamid Boulares, J. Biol. Chem., Aug 1999; 274: 22932. Alessandra Pagano, Am J Physiol Lung Cell Mol Physiol, Jun 2007; 10.1152.Mi Young Kim, Genes & Dev., Sep 2005; 19: 1951 – 1967. Silke S篓鹿sse, Nucleic Acids Res., Feb 2004; 32: 669 – 680. |
Specification | |
---|---|
Aliases | Cyclin-L; CCNL1; |
Entrez GeneID | 57018; |
Swissprot | Q9UK58 |
WB Predicted band size | 60kDa |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human,Mouse,Rat |
Immunogen | Synthesized peptide derived from human Cyclin-L1. |
Formulation | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Application | |
---|---|
WB | 1/500-1/3000 |
IHC | 1/50-1/100 |
![]() |
Western blot analysis of extracts from HepG2 cells, using Cyclin-L1 antibody P41827. |
![]() |
Western blot analysis of extracts from HeLa cells (Lane 2), A549 cells (Lane 3) and HepG2 cells (Lane 4), using Cyclin-L1 antiobdy P41827. The lane on the left is treated with systhesized peptide. |
![]() |
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using Cyclin-L1 antibody P41827. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
发表回复